• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Euscaphic acid Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5759884

Euscaphic acid has anti-diabetic, and anti-inflammatory activities, it inhibits LPS-induced inflammatory responses by interference with the clustering of TRAF6 with IRAK1 and TAK1, resulting in blocking the activation of IKK and MAPKs signal transduction to… More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Euscaphic acid, Inhibitor
Full Product Name
Euscaphic acid
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
488.71
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C30H48O5
SMILES
C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)C[C@@H](O)[C@@H](O)C(C)(C)C5CC[C@@]34C)C2[C@]1(C)O)C(O)=O
CAS Number
53155-25-2
Target & IC50
LDL
NO Synthase
PGE
In Vitro
Isolated aorta was used to test the anti-contraction effects and the possible mode of action(s) of the EA (1*10 -7 M) and (3*10 -7 M) isolated from Crataegus azarolus var. aronia L. Euscaphic acid showed high anti-contraction effects on norepinephrin (NE), (1*10 -9 -10 -4 M) induced contraction in aortic smooth muscle cells in endothelium-intact, endothelium-denuded, and aortic rings pre-incubated with potassium (K +)-channels blocker (tetraethylammonium, TEA), prostaglandin I 2 (PGI) inhibitor (indomethacin) and cyclic guanosine monophosphate (cGMP) inhibitor (methylene blue). On the other hand, other K 2 channels subtype blockers glibenclamide (GLIB); barium chloride (BaCl) and 4-aminopyridine (4-AP) demonstrated that adenosine triphosphate sensitive K + (K ATP), inwardly rectifying K 2 + (K ir) and voltage-dependent K) channels played no role in anti-contraction induced by EA. Furthermore, the role of L-types calcium (Ca) channels in EA anti-contractile effects on aortic smooth muscle cells was proved, by using the Ca -channel blocker verapamil, as indicated by the production of a potent anti-contraction effect. The results of the current study indicate that the anti-contraction effects of EA may be due to the activation of calcium dependent, K) channels and blocking of L-type Ca ++ channels.

Product References and Citations for Euscaphic acid, inhibitor

Anti-Contraction Effects of Euscaphic Acid Isolated from Crataegus azarolus var. aronia L on Rats Aortic Smooth Muscle. Adv Life Sci. Technol., 2015, 33.

Other Notes

Small volumes of Euscaphic acid, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Euscaphic acid purchase

MBS5759884 is an inhibitor targeting Euscaphic acid.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000